Each row is an authorised trial looking for participants. The plain-language title is written by our editorial team, and underneath it you can see the original registry title — so you can check for yourself that we did not change the meaning. We cannot tell you whether you are eligible, and we do not publish the hospital name: the international registry does not carry it, and a wrong name would send you to a room where nobody expects you. For the centre and the team's contact details, open the official record.
Trials recruiting now
Every title below has been rewritten in plain language by our editorial team, with the original underneath.
Advanced melanoma, not treated before: a new immunotherapy compared with nivolumab
A treatment is being testedPhase 3
Running in: L'Institute Oncologique Prof. Dr. Ion Chiricuta (IOCN) (The Oncology Institute Prof. Dr. Ion. Chiricuta), Cluj-Napoca · Sf Nectarie Oncology Center, Craiova · Victoria Hospital (Centrul de oncologie Euroclinic SRL) (Centrul De Oncologie Medicala) (Euroclinic Onchology Center), Iași
Registry title: IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
The counts are read automatically from ClinicalTrials.gov and show trials marked there as recruiting, with at least one site in Romania. We do not verify each one by hand, and we cannot guarantee that a trial marked “recruiting” is still taking patients today — the registry lags behind what happens in the hospital. For any decision, the official record and your doctor have the final word.
